Delivery Order SPE2DR25D1022-SPE2DR26FQT7D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,684.75 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $4,162.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract, which carried no set-aside designation, was fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.12 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $3,751.97 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 11, 2025, with a completion date of December 12, 2025. This non-competitive delivery order represents a firm fixed price transaction performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a $5,418.00 delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of January 2, 2026. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.33 for Oseltamivir Phosphate 30 mg capsules in unit dose packaging of 10s, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $2,109.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit dose packaging on January 6, 2026, with completion scheduled for January 7, 2026. This award is a non-set-aside competitive contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,699.70 delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQT7DDelivery Order
The Defense Logistics Agency awarded a $3,133.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (unit dose, 10-count packaging) on January 6, 2026, with completion targeted for January 7, 2026. The award was made without set-aside restrictions through open competition. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order represents a routine pharmaceutical procurement supporting federal military healthcare operations. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a prime vendor for DLA's medical supply chain, supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and veterans' healthcare programs. The small order value and one-day completion window reflect the efficiency of the larger IDC structure in enabling rapid procurement of essential medications for military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/5/26 |